Global Transplant diagnostics market Trend and Its Expected to Reach at a CAGR of 7.2% during forecast period 2017-2023

Market Research Future published a half-cooked research report on global transplant diagnostics market. Which is expected to Reach at a CAGR of 7.2% during forecast period 2017-2023

Global Transplant Diagnostics Market Research Report, By Products (Instrument, Reagent, Software And Services), By Technology (Non-Molecular Assay, Molecular Assay), By Application (Heart, Lungs, Liver, Kidney And Other), By Method Type (Pre-Transplant Screening And Post-Transplant Screening), By End Users (Hospitals, Transplants Centres, Research Laboratories And Other) -Forecast Till 2023

Transplant diagnostic is the method used to diagnose the compatibility of the replaced organ. Organ transplantation is a medical procedure in which an organ is removed from the one boy and placed in other body to swap the damaged or missing organ. Kidney is the most widely transplanted organ across the world. Global transplant diagnostics market is driven by increasing number of transplantation procedures across the globe. Increasing prevalence of chronic diseases, advanced in the diagnostic methods and increasing healthcare expenditure has also contributed in the growth of the market. On other hand, limited number of donor and high cost of diagnostic method has hamper the growth of the market. Global transplant diagnostics market is expected to grow at a CAGR of 7.2% during forecasted period.

Get a sample report at https://www.marketresearchfuture.com/sample_request/1324 .

Segmentation:
Global transplant diagnostics market is segmented on the basis of products into instrument, reagent, software and services. On the basis of technology the market is segmented into non-molecular assay and molecular assay. Non-molecular is further segmented into serological assay and mixed lymphocyte culture. Molecular assay is further segmented into sequenced base and PCR based. On the basis of application the market is segmented into heart, lungs, liver, kidney and other. On the basis of method type the market is segmented into pre-transplant screening and post-transplant screening and on the basis of end user the market is segmented as hospitals, transplants centers, research laboratories and other.

The major key player for the global transplant diagnostics market are 

 

  • Thermo Fisher Scientific, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Becton Dickinson and Company (US)
  • Abbott Laboratories Inc (US)
  • CareDx (US)
  • QIAGEN N.V. (Netherlands)
  • Immucor, Inc. (US)
  • GenDx (Netherlands)
  • Omixon Ltd. (UK)
  • bioMérieux S.A. (France)
  • Illumina, Inc. (US)
  • Immucor Transplant Diagnostics, Inc (US)
  • Affymetrix, Inc (US)
  • Linkage Biosciences (US)

Complete Report Available at https://www.marketresearchfuture.com/reports/transplant-diagnostics-market-1324 .

 

Global transplant diagnostics market is contributed by many of the small and large companies. Major companies are investing in R&D so as to introduce more innovative and efficientdiagnostics methods as they are under constant pressure to launch new and cost-effective method.
Thermo Fisher Scientific, Inc is American multinational company headquartered in US. Thermo Fisher Scientific, Inc. holds the first position in the global transplant diagnostics market. Company has introduces different antibody, HLA Transplant Diagnostics Products, transplant-related biomarker and many more. Electro-Fast and OWL Centipede systems and DNA Isolation Kit are the products of the company. SeCore one of the product for high-resolution HLA typing products. Company has introduced PlexMark which is a highly specific assay with extremely low cross-reactivity perform during renal transplants.
Bio-Rad Laboratories, Inc. is the US headquartered company which develops, manufacture and market the wide range of products for clinical diagnostics and research. In Feb 2016, company has got approval for the QX200, Droplet Digital PCR System which are the first digital PCR system with the CE IVD mark for use as an in vitro diagnostic equipment. 

Global transplant diagnostics market is segmented on the basis of products into instrument, reagent, software and services. On the basis of technology the market is segmented into non-molecular assay and molecular assay. Non-molecular is further segmented into serological assay and mixed lymphocyte culture. Molecular assay is further segmented into sequenced base and PCR based. On the basis of application the market is segmented into heart, lungs, liver, kidney and other. On the basis of method type the market is segmented into pre-transplant screening and post-transplant screening and on the basis of end user the market is segmented as hospitals, transplants centres, research laboratories and other. 

 

Get a discount at https://www.marketresearchfuture.com/check-discount/1324 .

The report for global transplant diagnostics market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/transplant-diagnostics-market